Eli Lilly: Worries Ahead In Patent Fight By: Stocks to Watch May 17, 2017 at 12:39 PM EDT Do investors under appreciate the downside risk the drug maker could face if it loses the next leg of the patent challenge on the cancer drug Alimta? Read More >>
